-
Appearance before the House of Commons Standing Committee on Health (HESA)...
(HESA) on Supplementary Estimates B -
CIHR President Transition Book- Part 2
CIHR President Transition Book- Part 2: CIHR Strategic Priorities -
Appearance before the House of Commons Standing Committee on Health (HESA)...
Canada’s research community is contributing to both the global and domestic response to COVID-19 and is well-poised for significant discoveries. -
Appearance before the House of Commons Standing Committee on Health (HESA)...
In submissions to the Standing Committee on Finance’s pre-budget 2024 consultation, health research stakeholders expressed support for implementation of the Advisory Panel’s... -
Appearance before the House of Commons Standing Committee on Science and...
International moonshot programs have led to major successes, improving livelihoods of people around the world. One example is the U.S. government-funded Cancer Moonshot which in... -
Appearance before the House of Commons Standing Committee on Health (HESA)...
TRANSFERS FROM HEALTH CANADA TO THE CANADIAN INSTITUTES OF HEALTH RESEARCH TO SUPPORT APPROACHES FOR TESTING – TABLING OF THE 2020–21 SUPPLEMENTARY ESTIMATES (C) -
Appearance before the House of Commons Standing Committee on Health (HESA)...
Supplementary estimates (B) 2020-21 CIHR -
Appearance before the Senate Standing Committee on National Finance
The Canadian Institutes of Health Research 2023-24 Main Estimates discussion -
Appearance before the House of Commons Standing Committee on Health (HESA)...
Health researchers continue to be supportive of the recommendations made in Canada’s Fundamental Science Review report (2017). Many stakeholders have called for increased...